학술논문
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind study
Document Type
Article
Author
Wan, Rui ; Dong, Xiaorong ; Chen, Qun; Yu, Yan; Yang, Shujun; Zhang, Xiaochun; Zhang, Guojun; Pan, Yueyin; Sun, Sanyuan; Zhou, Chengzhi; Hong, Wei; Zhao, Hui; Yang, Lei; Huang, Linian; Wu, Rong; Zang, Aimin; Ma, Rui; Wu, Lin; Lv, Dongqing; Fu, Xiuhua; Han, Jianguo; Li, Wenxin; Duan, Jianchun; Wang, Kai; Jiang, Ou; Chen, Yinglan; Guo, Zhongliang; Gao, Hongjun; Wen, Juyi; Wang, Shubin; Zhao, Enfeng; Li, Gaofeng; Yue, Lu; Liang, Li; Zeng, Aiping; Wang, Xiaoshan; Zhu, Yuxi; Pan, Hongming; Dai, Zhaoxia; Feng, Weineng; Zhao, Guofang; Lin, Chuan; Li, Chong; Li, Na; Bao, Yangyi; Li, Yinyin; Su, Yanjun; Zhao, Min; Fang, Haohui; Zhu, Yulong; Zhang, Yu; Ding, Lieming; Wang, Yang; Yuan, Xiaobin; Wang, Jie
Source
In eClinicalMedicine December 2021 42
Subject
Language
ISSN
2589-5370